These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


402 related items for PubMed ID: 22178778

  • 21. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [Abstract] [Full Text] [Related]

  • 22. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
    Jackson RD, Wactawski-Wende J, LaCroix AZ, Pettinger M, Yood RA, Watts NB, Robbins JA, Lewis CE, Beresford SA, Ko MG, Naughton MJ, Satterfield S, Bassford T, Women's Health Initiative Investigators.
    J Bone Miner Res; 2006 Jun; 21(6):817-28. PubMed ID: 16753012
    [Abstract] [Full Text] [Related]

  • 23. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures.
    Hochberg MC, Thompson DE, Black DM, Quandt SA, Cauley J, Geusens P, Ross PD, Baran D, FIT Research Group.
    J Bone Miner Res; 2005 Jun; 20(6):971-6. PubMed ID: 15883637
    [Abstract] [Full Text] [Related]

  • 24. Predictors of fractures in elderly women.
    Tromp AM, Ooms ME, Popp-Snijders C, Roos JC, Lips P.
    Osteoporos Int; 2000 Jun; 11(2):134-40. PubMed ID: 10793871
    [Abstract] [Full Text] [Related]

  • 25. Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.
    van Geel TA, Geusens PP, Nagtzaam IF, van der Voort DJ, Schreurs CM, Rinkens PE, Dinant GJ.
    Menopause Int; 2007 Sep; 13(3):110-5. PubMed ID: 17785036
    [Abstract] [Full Text] [Related]

  • 26. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
    Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C.
    Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Physical activity slows femoral bone loss but promotes wrist fractures in postmenopausal women: a 15-year follow-up of the OSTPRE study.
    Rikkonen T, Salovaara K, Sirola J, Kärkkäinen M, Tuppurainen M, Jurvelin J, Honkanen R, Alhava E, Kröger H.
    J Bone Miner Res; 2010 Nov; 25(11):2332-40. PubMed ID: 20533310
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ, Naganathan V, Barton I, Grauer A.
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [Abstract] [Full Text] [Related]

  • 32. Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women.
    Antoniucci DM, Sellmeyer DE, Cauley JA, Ensrud KE, Schneider JL, Vesco KK, Cummings SR, Melton LJ, Study of Osteoporotic Fractures Research Group.
    J Bone Miner Res; 2005 May; 20(5):741-7. PubMed ID: 15824846
    [Abstract] [Full Text] [Related]

  • 33. Weight change and fractures in older women. Study of Osteoporotic Fractures Research Group.
    Ensrud KE, Cauley J, Lipschutz R, Cummings SR.
    Arch Intern Med; 1997 Apr 28; 157(8):857-63. PubMed ID: 9129545
    [Abstract] [Full Text] [Related]

  • 34. Total calcium intake is associated with cortical bone mineral density in a cohort of postmenopausal women not taking estrogen.
    Suzuki Y, Whiting SJ, Davison KS, Chilibeck PD.
    J Nutr Health Aging; 2003 Apr 28; 7(5):296-9. PubMed ID: 12917743
    [Abstract] [Full Text] [Related]

  • 35. Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort.
    Rubin LA, Hawker GA, Peltekova VD, Fielding LJ, Ridout R, Cole DE.
    J Bone Miner Res; 1999 Apr 28; 14(4):633-43. PubMed ID: 10234586
    [Abstract] [Full Text] [Related]

  • 36. Frequency of FRAX risk factors in osteopenic postmenopausal women with and without history of fragility fracture.
    Baró F, Cano A, Sánchez Borrego R, Ferrer J, González Rodríguez SP, Neyro JL, Rodriguez Bueno E, Sancho C, Inaraja V, Fernández C, Corral C, FROSPE Study Group.
    Menopause; 2012 Nov 28; 19(11):1193-9. PubMed ID: 22948137
    [Abstract] [Full Text] [Related]

  • 37. [Is there a role for a random measurement of 24-hour urine calcium excretion and serum total alkaline phosphatase in the determination of fracture risk in osteoporotic postmenopausal women?].
    Barbu C, Roman A, Rotaru R, Fica S.
    Rev Med Chir Soc Med Nat Iasi; 2006 Nov 28; 110(2):291-4. PubMed ID: 17802933
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study.
    Garnero P, Munoz F, Sornay-Rendu E, Delmas PD.
    Bone; 2007 Mar 28; 40(3):716-22. PubMed ID: 17112798
    [Abstract] [Full Text] [Related]

  • 40. Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?
    Bagger YZ, Rasmussen HB, Alexandersen P, Werge T, Christiansen C, Tankó LB, PERF study group.
    Osteoporos Int; 2007 Apr 28; 18(4):505-12. PubMed ID: 17109061
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.